Do cost-sharing and entry deregulation curb pharmaceutical innovation?
presented at CESifo Area Conference on Public Sector Economics, April 2011
Our rough guess is there are 10,250 words in this book.
At a pace averaging 250 words per minute, this book will take 0 hours and 41 minutes to read. With a half hour per day, this will take 2 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Word Count
10,250 words, Guess
Page Count
41 pages
Identifiers
- OCLC Control Number748702146
- Open LibraryOL38579022M
Classifications
- DDC650
- DDC330
Subjects
Topics
MarktzugangPharmakologieProduktivitätWachstumstheorieSelbstbeteiligungGesundheitsökonomieArzneimittelforschungForschungsfinanzierungMarkteintrittsstrategieEndogenes WirtschaftswachstumGesetzliche Krankenversicherung
Series Statement
- CESifo working papers -- No. 3439 : Category 1, Public finance
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!